Coherus Oncology Announces Publication in Molecular Cancer Therapeutics Highlighting the Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug
Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma
Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody
Blackrock Silver Announces the Appointment of Bernard Poznanski and Susan Mathieu to the Board of Directors
Fortune Bay Drills Multiple Gold Zones at Goldfields including 6.61 g/t over 5.0 m within 2.54 g/t over 17.0 m
